bonyf NV / Key word(s): Annual Results bonyf NV: bonyf’s 2023 financial statements made available 28-Jun-2024 / 17:12 CET/CEST
Dissemination of a Financial Wire News, transmitted by EQS Group. |
‘Significant Milestone’ for Radionuclide Therapy in Refractory Meningioma
Use of an approved radionuclide therapy for difficult-to-treat meningioma was associated with substantially improved progression-free survival (PFS) compared with a historical benchmark, according to results